34
Participants
Start Date
February 9, 2023
Primary Completion Date
January 26, 2024
Study Completion Date
March 23, 2024
MG-ZG122 Humanized Monoclonal Antibody Injection
Single subcutaneous injection. Subjects with a dose of less than or equal to 2 ml were given one injection, and subjects with a dose of more than 2 ml were given two injections. A group 0.5 ml, B group 1 ml, C group 2 ml, D group 4 ml.
Placebo
Single subcutaneous injection. Subjects with a dose of less than or equal to 2 ml were given one injection, and subjects with a dose of more than 2 ml were given two injections. A group 0.5 ml, B group 1 ml, C group 2 ml, D group 4 ml.
The Second Affiliated Hospital of Anhui Medical University, Hefei
Shanghai Mabgeek Biotech.Co.Ltd
OTHER_GOV